- Conditions
- Vitreomacular Attachment, Vitreomacular Traction, Vitreomacular Adhesion
- Interventions
- 36% Resolvine Intravitreal Injection, 9% Resolvine Intravitreal Injection
- Drug
- Lead sponsor
- Jeffrey S Heier
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 2
- States / cities
- Beverly Hills, California • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 30, 2016 · Synced May 22, 2026, 5:37 AM EDT